Table 4.
Pathological features of resected specimens from patients who underwent surgery.
| Pathological features | All n=48 (%) |
Chemotherapy n=13 (%) |
Immunotherapy n=26 (%) |
Targeted therapy n=9 (%) |
P-value |
|---|---|---|---|---|---|
| Tumor infiltrating lyphocytesa | 0.631* | ||||
| <30% | 33 (68.8) | 9 (69.2) | 19 (73.1) | 5 (55.6) | |
| ≥30% | 15 (31.3) | 4 (30.8) | 7 (26.9) | 4 (44.4) | |
| Dense plasma cells | 0.661* | ||||
| Absent | 34 (70.8) | 10 (76.9) | 17 (65.4) | 7 (77.8) | |
| Present | 14 (29.2) | 3 (23.1) | 9 (34.6) | 2 (22.2) | |
| Cholesterol clefts | 0.616* | ||||
| Absent | 41 (85.4) | 12 (92.3) | 22 (84.6) | 7 (77.8) | |
| Present | 7 (14.6) | 1 (7.7) | 4 (15.4) | 2 (22.2) | |
| Foamy macrophages | 0.018* | ||||
| Absent | 33 (68.8) | 13 (100) | 20 (76.9) | 9 (100) | |
| Present | 6 (12.5) | 0 (0) | 6 (23.1) | 0 (0) | |
| Proliferative fibrosis | 0.498* | ||||
| Absent | 10 (20.8) | 2 (15.4) | 7 (26.9) | 1 (11.1) | |
| Present | 38 (79.2) | 11 (84.6) | 19 (73.1) | 8 (88.9) | |
| Hyalinization | 0.739* | ||||
| Absent | 40 (83.3) | 10 (76.9) | 22 (84.6) | 8 (88.9) | |
| Present | 8 (16.7) | 3 (23.1) | 4 (15.4) | 1 (11.1) | |
| Giant cells | 0.589* | ||||
| Absent | 37 (77.1) | 10 (76.9) | 19 (73.1) | 8 (88.9) | |
| Present | 11 (22.9) | 3 (23.1) | 7 (26.9) | 1 (11.1) | |
| Necrosis | 0.324 | ||||
| Absent | 29 (60.4) | 6 (46.2) | 16 (61.5) | 7 (77.8) | |
| Present | 19 (39.6) | 7 (53.8) | 10 (38.5) | 2 (22.2) | |
*likelihood ratio.
The bold values denote statistical significance at P<0.05 level.